CAMK1D and PI3 in low-density neutrophils are associated with the anti-hypertensive effects of valsartan
Related Experiment Video
Updated: Feb 4, 2026

Isolation and Characterization of Neutrophils with Anti-Tumor Properties
Published on: June 19, 2015
Bang-Bang Huang1, Xing Yu2, Zhi-Dian Cai1
1Department of Geriatrics, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China; Department of Geriatrics, The First Affiliated Hospital of Fujian Medical University, Fujian Medical University, Fuzhou, China; Fujian Hypertension Research Institute, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China; Clinical Research Center for Geriatric Hypertension Disease of Fujian Province, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China; Branch of National Clinical Research Center for Aging and Medicine, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Insights
Valsartan treatment impacts low-density neutrophils (LDNs) in hypertension by altering gene expression, specifically reducing immune activation markers. This suggests LDNs play a role in valsartan
Area of Science:
- Cardiovascular Medicine
- Immunology
- Pharmacogenomics
Background:
- Hypertension is a major global health concern.
- Low-density neutrophils (LDNs) contribute to vascular damage via immune activation.
- Understanding LDN mechanisms in hypertension is crucial for effective treatment.
Purpose of the Study:
- To investigate valsartan's effects on LDNs in hypertensive patients.
- To identify molecular mechanisms of LDN involvement in valsartan response.
- To explore potential therapeutic targets for hypertension.
Main Methods:
- Single-cell RNA sequencing of peripheral blood mononuclear cells (PBMCs) before and after valsartan treatment.
- Mendelian randomization (MR) analysis to identify genes linked to valsartan response.
- Analysis of LDN subtypes (CAMK1D, PI3, ISG15, S100A12) and gene expression.
Main Results:
- Valsartan treatment modulated immune activation transcripts in LDNs.
- Specific changes observed: decreased CAMK1D and increased PI3 expression.
- Lower MMP9 in PI3 subtype correlated with reduced LDN differentiation into CAMK1D subtype.
Conclusions:
- CAMK1D and PI3 are key LDN-related genes influencing valsartan response in hypertension.
- Valsartan may enhance efficacy by promoting LDN retention in the PI3 subtype.
- Findings provide a basis for future functional studies on LDNs and hypertension treatment.
Abstract:
Hypertension remains a significant global health issue. Low-density neutrophils (LDNs), a subset of neutrophils, contribute to vascular injury through immune activation. This study aimed to explore the effects of valsartan on LDNs in hypertension and to elucidate the molecular mechanisms underlying their role in therapeutic response. Newly diagnosed hypertensive patients received 80 mg/day valsartan for one month. Single-cell RNA sequencing was performed on peripheral blood mononuclear cells (PBMCs) collected before and after treatment. Mendelian randomization (MR) analysis was used to identify genes associated with valsartan response among the differentially expressed genes. Eleven cell subpopulations were identified, including four distinct LDN subtypes: CAMK1D, PI3, ISG15, and S100A12. Valsartan treatment reduced immune activation-related transcripts in LDNs, with decreased CAMK1D and increased PI3 expression. Lower MMP9 transcript levels in the PI3 subtype were linked to limited differentiation of LDNs into the CAMK1D subtype, with a preference for retention in the PI3 subtype, potentially contributing to valsartan's ehanced efficacy. Theses findings highlight CAMK1D and PI3 as LDN-related genes influencing valsartan response in hypertension, offering a foundation for future functional studies.
More Related Videos
07:17The Isolation and Characterization of Low- and Normal- Density Neutrophils from Whole Blood
Published on: February 7, 2025
08:59Neutrophil Extracellular Traps Generated by Low Density Neutrophils Obtained from Peritoneal Lavage Fluid Mediate Tumor Cell Growth and Attachment
Published on: August 3, 2018
Related Concept Videos
Hypertension I: Introduction
Hypertension II: Pathophysiology
Density
Hypertension V: Nursing Management
Current Density
Buffer Effectiveness
The buffer capacity is the amount of acid or base that can be added to a given volume...